Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 5
2014 1
2015 4
2016 2
2017 1
2018 3
2019 6
2020 4
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yingxiu zhang (80 results)?
The Anticancer Potential of Apigenin Via Immunoregulation.
Xu L, Zaky MY, Yousuf W, Ullah A, Abdelbaset GR, Zhang Y, Ahmed OM, Liu S, Liu H. Xu L, et al. Among authors: zhang y. Curr Pharm Des. 2021;27(4):479-489. doi: 10.2174/1381612826666200713171137. Curr Pharm Des. 2021. PMID: 32660399 Review.
Heme oxygenase and ocular disease: a review of the literature.
Zhao J, Tan S, Liu F, Zhang Y, Su M, Sun D. Zhao J, et al. Among authors: zhang y. Curr Eye Res. 2012 Nov;37(11):955-60. doi: 10.3109/02713683.2012.700753. Epub 2012 Jun 21. Curr Eye Res. 2012. PMID: 22720721 Review.
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
Zhang J, Liu S, Li Q, Shi Y, Wu Y, Liu F, Wang S, Zaky MY, Yousuf W, Sun Q, Guo D, Wang T, Zhang Y, Wang Y, Li M, Liu H. Zhang J, et al. Among authors: zhang y. Cell Death Differ. 2020 Sep;27(9):2710-2725. doi: 10.1038/s41418-020-0538-8. Epub 2020 Apr 23. Cell Death Differ. 2020. PMID: 32327714 Free PMC article.
27 results